Journal of Clinical Medicine · 2023 · 21 citations · 54 references
MedicineOrthopaedic SurgeryPediatricsPediatric OrthopaedicsPediatric RheumatologyRheumatologyInflammatory ArthritisInflammatory Disease PathologyJoint DiseaseOsteomyelitisAutoinflammatory Disease PhenotypingAutoinflammatory Skin DiseaseChronic Recurrent OsteomyelitisDisease ModifiersInflammatory SpondyloarthritisIntestinal DysbiosisJuvenile ArthritisPediatric-onset Autoinflammatory Disease
Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disease occurring mainly in the pediatric age group (before 16 years) and generally presents as a separate entity. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome combines osteoarticular and cutaneous involvement, similar to CRMO, and falls into the spectrum of spondyloarthritis (SpA). The fact that a patient can progress from one disease to another raises the question of whether CRMO, like SAPHO, could fall within the spectrum of SpA, ranging from a predominantly osteoarticular form to an enthesitic form with more or less marked skin involvement. In this review, we set out to discuss this hypothesis by highlighting the differences and similarities between CRMO and juvenile SpA in clinical, radiological and pathophysiological aspects. A common hypothesis could potentially consider intestinal dysbiosis as the origin of these different inflammatory diseases. Interindividual factors such as gender, environment, genetics and/or epigenetic background could act as combined disease modifiers. This is why we suggest that pathophysiology, rather than clinical phenotype, be used to reclassify these diseases.
54
Human gut microbiome viewed across age and geography
Tanya Yatsunenko, Federico E. Rey, Mark Manary et al. · Nature · 2012 · 7.9K citations · Full text
Life Sciences, Biology, Microbiology +10
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Dermatology, Immunology +14
Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky et al. · Gut · 2012 · 1.5K citations · Full text
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten, Joachim Sieper, Jürgen Braun et al. · New England Journal of Medicine · 2015 · 1K citations · Full text